36 results on '"de Castro, Luis F."'
Search Results
2. An inducible explant model of osteoclast-osteoprogenitor coordination in exacerbated osteoclastogenesis
3. Murine models of HRAS-mediated cutaneous skeletal hypophosphatemia syndrome suggest bone as the FGF23 excess source
4. RNA-based bone histomorphometry: method and its application to explaining postpubertal bone gain in a G610C mouse model of osteogenesis imperfecta
5. Fibrous Dysplasia: A Mathematical Model of in Vitro Growth and Denosumab Treatment
6. Malignant Sarcomatous Degeneration of Craniofacial Fibrous Dysplasia
7. Successful Intravascular Treatment of an Intraosseous Arteriovenous Fistula in Fibrous Dysplasia
8. Combinatorial cassettes to systematically evaluate tissue-engineered constructs in recipient mice
9. RANKL inhibition reduces lesional cellularity and Gαs variant expression and enables osteogenic maturation in fibrous dysplasia.
10. Safety and Efficacy of Denosumab for Fibrous Dysplasia of Bone
11. Identification ofGNASVariants in Circulating Cell‐Free DNA from Patients with Fibrous Dysplasia/ McCune Albright Syndrome
12. An inducible explant model for dissecting osteoclast-osteoblast coordination in health and disease
13. RANKL inhibition with denosumab improves fibrous dysplasia by decreasing lesional cell proliferation and increasing osteogenesis
14. Determination of FGF23 Levels for the Diagnosis of FGF23‐Mediated Hypophosphatemia
15. Identification of GNAS Variants in Circulating Cell-Free DNA from Patients with Fibrous Dysplasia/McCune Albright Syndrome.
16. Malignant Sarcomatous Degeneration of Craniofacial Fibrous Dysplasia
17. Genotype-Phenotype Correlation in Fibrous Dysplasia/McCune-Albright Syndrome
18. DIAGNOSIS OF ENDOCRINE DISEASE: Mosaic disorders of FGF23 excess: Fibrous dysplasia/McCune–Albright syndrome and cutaneous skeletal hypophosphatemia syndrome
19. Role of Parathyroid Hormone-Related Protein in the Decreased Osteoblast Function in Diabetes-Related Osteopenia
20. RANKL inhibition reduces lesional cellularity and Gαsvariant expression and enables osteogenic maturation in fibrous dysplasia
21. Activation of RANK/RANKL/OPG Pathway Is Involved in the Pathophysiology of Fibrous Dysplasia and Associated With Disease Burden
22. Manufacturing Differences Affect Human Bone Marrow Stromal Cell Characteristics and Function: Comparison of Production Methods and Products from Multiple Centers
23. p53 Loss Increases the Osteogenic Differentiation of BMSCs
24. Activation of RANK/RANKL/OPG Pathway Is Involved in the Pathophysiology of Fibrous Dysplasia and Associated With Disease Burden.
25. Role of the Parathyroid Hormone Type 1 Receptor (PTH1R) as a Mechanosensor in Osteocyte Survival
26. p53 Loss Increases the Osteogenic Differentiation of Bone Marrow Stromal Cells
27. VEGF Receptor 2 (VEGFR2) Activation Is Essential for Osteocyte Survival Induced by Mechanotransduction
28. Biglycan modulates angiogenesis and bone formation during fracture healing
29. IGF-I increases markers of osteoblastic activity and reduces bone resorption via osteoprotegerin and RANK-ligand
30. WISP1/CCN4: A Potential Target for Inhibiting Prostate Cancer Growth and Spread to Bone
31. VEGF Receptor 2 (VEGFR2) Activation Is Essential for Osteocyte Survival Induced by Mechanotransduction.
32. Zum bindungsmechanismus des interstitiellen Fe-atoms in FeTh6Br15
33. Cómo reducir el coste de producción del pollo
34. Guidelines for Micro-Computed Tomography Analysis of Rodent Dentoalveolar Tissues.
35. In Vivo Formation of Stable Hyaline Cartilage by Naïve Human Bone Marrow Stromal Cells with Modified Fibrin Microbeads.
36. Fibrous Dysplasia/McCune-Albright Syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.